Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 5
Submit an article Journal homepage
354
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center

Alicia McGhiea Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jenessa Leea Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Alessandra Ferrajolib Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Adam J. DiPippoa Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5986-0190View further author information
ORCID Icon
Pages 1050-1053 | Received 24 Jan 2023, Accepted 22 Feb 2023, Published online: 08 Mar 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgments

Chun Feng, M.A., Certified ASQ Six Sigma Black Belt, Sr. Informatics Analyst – Department of Pharmacy – Quality and Regulatory, Division of Pharmacy, University of Texas M.D. Anderson Cancer Center.

Author contributions

Alicia McGhie provided study design, collection and analysis of data and writing of the manuscript. Jenessa Lee provided study design, analyzed data, and review of the manuscript. Alessandra Ferrajoli provided study design, contributed patients, and reviewed and edited the manuscript. Adam J. DiPippo provided study design, collected and analyzed data, and reviewed and edited the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

A.F.: research funds: Astra-Zeneca and Beigene, advisory board: Janssen, Astra-Zeneca.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.